Clinical Trials Directory

Trials / Completed

CompletedNCT03348228

Effect of Hydroxycitrate on Urine Chemistry

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Hydroxycitrate (HCA) is a compound extracted from the fruit, Garcinia Cambogia. Hydroxycitrate supplements are available over the counter and are primarily promoted as a weight loss supplement. There has been recent evidence that hydroxycitrate is a potent inhibitor of calcium oxalate crystal growth and can lead to the dissolution of the crystals. The purpose of this research study is to study the effect of Hydroxycitrate (HCA) supplements on HCA urinary excretion and on urine chemistries in kidney stone formers and normal subjects.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHydroxycitrate (HCA)Hydroxycitrate supplements are available over the counter and are primarily promoted as a weight loss supplement. Each subject will be given 42 capsules of Swanson super citrimax (hydroxycitrate) Details of the product are provided above. The subjects will be asked to take the capsules over a seven period (6 capsules per day).

Timeline

Start date
2018-10-04
Primary completion
2020-12-15
Completion
2020-12-15
First posted
2017-11-20
Last updated
2022-01-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03348228. Inclusion in this directory is not an endorsement.